Lanean...
STAT3 INHIBITION AUGMENTS THE IMMUNOGENICITY OF MALIGNANT B-CELLS LEADING TO EFFECTIVE ANTITUMOR IMMUNITY IN B-CELL LYMPHOMAS
Mantle cell lymphoma (MCL) is an aggressive and incurable subtype of B-cell Non-Hodgkin’s lymphomas characterized by an initial response to first-line treatment with chemotherapy plus monoclonal antibodies followed by relapse and less responsiveness to further lines of treatment. Harnessing the immu...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3990429/ https://ncbi.nlm.nih.gov/pubmed/22728650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-3619 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|